A fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effects
dc.article.end-page | 32 | en |
dc.article.start-page | 1 | en |
dc.citation.doi | 10.1038/S41598-024-66531-X | en |
dc.contributor.author | D Amilo | en |
dc.contributor.author | Chinedu Izuchukwu | en |
dc.contributor.author | K Sadri | en |
dc.contributor.author | Hao-Ren Yao | en |
dc.contributor.author | E Hincal | en |
dc.contributor.author | Y Shehu | en |
dc.date.accessioned | 2024-09-16T13:18:57Z | |
dc.date.available | 2024-09-16T13:18:57Z | |
dc.faculty | FACULTY OF SCIENCE | en |
dc.identifier.citation | WOS | en |
dc.identifier.uri | https://hdl.handle.net/10539/40839 | |
dc.journal.title | A fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effects | en |
dc.journal.volume | 14 | en |
dc.school | 5.06 | en |
dc.title | A fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effects | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 2.95 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client